Vaccines for conferring immunity in mammals to infective pathogens are provided, as well as vectors and methods for plastid transformation of plants to produce protective antigens and vaccines for oral delivery. The invention further provides transformed plastids having the ability to survive selection in both the light and the dark, at different developmental stages by using genes coding for two different enzymes capable of detoxifying the same selectable marker, driven by regulatory signals that are functional in proplastids as well as in mature chloroplasts. The invention utilizes antibiotic-free selectable markers to provide edible vaccines for conferring immunity to a mammal against Bacillus anthracis, as well as Yersina pestis. The va...
The oral vaccines and oral vaccine adjuvants of the present invention are produced in transgenic pla...
The Centers for Disease Control (CDC) lists Bacillus anthracis as a category A agent and estimates t...
The Centers for Disease Control (CDC) lists Bacillus anthracis as a category A agent and estimates t...
Vaccines for conferring immunity in mammals to infective pathogens are provided, as well as vectors ...
Transgenic plants offer many advantages, including low cost of production (by elimination of ferment...
Transgenic plants offer many advantages, including low cost of production (by elimination of ferment...
Since the development of methodologies for achieving genetic modification of chloroplast genomes, te...
Transgenic plants offer many advantages, including low cost of production (by elimination of ferment...
Plant derived oral green vaccines eliminate expenses associated with fermenters, purification, cold ...
The vaccines are very effective vehicles for the prevention of various diseases. The cost of product...
Plant derived oral green vaccines eliminate expenses associated with fermenters, purification, cold ...
Stable integration of a gene into the plant nuclear or chloroplast genome can transform higher plant...
Despite the development of advanced vaccine technology, as many as 15 million deaths occur annually ...
Plant derived oral green vaccines eliminate expenses associated with fermenters, purification, cold ...
Many vaccine antigens and biopharmaceutical proteins have been expressed at high levels via the chlo...
The oral vaccines and oral vaccine adjuvants of the present invention are produced in transgenic pla...
The Centers for Disease Control (CDC) lists Bacillus anthracis as a category A agent and estimates t...
The Centers for Disease Control (CDC) lists Bacillus anthracis as a category A agent and estimates t...
Vaccines for conferring immunity in mammals to infective pathogens are provided, as well as vectors ...
Transgenic plants offer many advantages, including low cost of production (by elimination of ferment...
Transgenic plants offer many advantages, including low cost of production (by elimination of ferment...
Since the development of methodologies for achieving genetic modification of chloroplast genomes, te...
Transgenic plants offer many advantages, including low cost of production (by elimination of ferment...
Plant derived oral green vaccines eliminate expenses associated with fermenters, purification, cold ...
The vaccines are very effective vehicles for the prevention of various diseases. The cost of product...
Plant derived oral green vaccines eliminate expenses associated with fermenters, purification, cold ...
Stable integration of a gene into the plant nuclear or chloroplast genome can transform higher plant...
Despite the development of advanced vaccine technology, as many as 15 million deaths occur annually ...
Plant derived oral green vaccines eliminate expenses associated with fermenters, purification, cold ...
Many vaccine antigens and biopharmaceutical proteins have been expressed at high levels via the chlo...
The oral vaccines and oral vaccine adjuvants of the present invention are produced in transgenic pla...
The Centers for Disease Control (CDC) lists Bacillus anthracis as a category A agent and estimates t...
The Centers for Disease Control (CDC) lists Bacillus anthracis as a category A agent and estimates t...